PRICE T ROWE ASSOCIATES INC /MD/ – Regeneron Pharmaceuticals, Inc. Transaction History
PRICE T ROWE ASSOCIATES INC /MD/ portfolio value:
$1.20B
portfolio value
PRICE T ROWE ASSOCIATES INC /MD/ quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +3.32% | 56.25K shares | 204.35M | $688.87 | 1.75M |
| Q2 2022 | share | Increase | +92.46% | 813.96K shares | 386.70M | $591.13 | 1.69M |
| Q1 2022 | share | Decrease | -3.60% | -32.91K shares | 38.10M | $698.42 | 880.34K |
| Q4 2021 | share | Increase | +12.77% | 103.41K shares | 86.64M | $642.51 | 913.25K |
| Q3 2021 | share | Decrease | -1.82% | -15.00K shares | 29.39M | $605.18 | 809.84K |
| Q2 2021 | share | Decrease | -4.39% | -37.89K shares | 52.51M | $558.54 | 824.84K |
| Q1 2021 | share | Decrease | -0.61% | -5.25K shares | -11.14M | $473.14 | 862.74K |
| Q4 2020 | share | Decrease | -5.03% | -45.99K shares | -92.29M | $483.11 | 867.99K |
| Q3 2020 | share | Decrease | -18.64% | -209.39K shares | -188.96M | $559.78 | 913.99K |
| Q2 2020 | share | Increase | +11.52% | 116.05K shares | 208.72M | $623.65 | 1.12M |
| Q1 2020 | share | Increase | +27.33% | 216.21K shares | 194.82M | $488.29 | 1.00M |
| Q4 2019 | share | Decrease | -8.75% | -75.87K shares | 56.54M | $375.48 | 791.12K |
| Q3 2019 | share | Increase | +7.78% | 62.59K shares | -11.27M | $277.4 | 867K |
| Q2 2019 | share | Decrease | -54.22% | -952.72K shares | -469.73M | $313 | 804.40K |
| Q1 2019 | share | Increase | +170.77% | 1.10M shares | 479.13M | $410.62 | 1.75M |
| Q4 2018 | share | Increase | +10.37% | 60.98K shares | 4.82M | $373.5 | 648.93K |
| Q3 2018 | share | Decrease | -16.47% | -115.93K shares | -5.27M | $404.04 | 587.95K |
| Q2 2018 | share | Increase | +2.05% | 14.13K shares | 5.30M | $344.99 | 703.88K |
| Q1 2018 | share | Decrease | -2.86% | -20.31K shares | -29.43M | $344.36 | 689.75K |
| Q4 2017 | share | Decrease | -7.99% | -61.66K shares | -78.1M | $375.96 | 710.06K |
| Q3 2017 | share | Decrease | -5.76% | -47.17K shares | -57.14M | $447.12 | 771.73K |
| Q2 2017 | share | Decrease | -26.35% | -292.96K shares | -28.66M | $491.14 | 818.90K |
| Q1 2017 | share | Increase | +2.97% | 32.08K shares | 34.48M | $387.51 | 1.11M |
| Q4 2016 | share | Decrease | -9.83% | -117.67K shares | -85.02M | $367.09 | 1.07M |
| Q3 2016 | share | Decrease | -34.06% | -618.52K shares | -152.79M | $402.02 | 1.19M |
| Q2 2016 | share | Decrease | -54.82% | -2.20M shares | -814.68M | $349.23 | 1.81M |
| Q1 2016 | share | Decrease | -15.16% | -718.51K shares | -1.12B | $360.44 | 4.01M |